Bar Harbor Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.89M Sell
5,764
-162
-3% -$77.8K 0.16% 116
2026
Q1
$2.91M Sell
5,926
-169
-3% -$91.7K 0.17% 113
2025
Q4
$3.53M Sell
6,095
-180
-3% -$102K 0.2% 97
2025
Q3
$3.04M Sell
6,275
-196
-3% -$91.2K 0.18% 106
2025
Q2
$2.62M Sell
6,471
-300
-4% -$125K 0.17% 111
2025
Q1
$3.37M Sell
6,771
-1,338
-17% -$725K 0.22% 97
2024
Q4
$4.22M Sell
8,109
-92
-1% -$50.6K 0.28% 89
2024
Q3
$5.07M Sell
8,201
-156
-2% -$92.3K 0.32% 79
2024
Q2
$4.62M Sell
8,357
-220
-3% -$126K 0.31% 83
2024
Q1
$4.99M Sell
8,577
-222
-3% -$125K 0.33% 82
2023
Q4
$4.67M Sell
8,799
-618
-7% -$299K 0.35% 78
2023
Q3
$4.77M Sell
9,417
-368
-4% -$196K 0.38% 71
2023
Q2
$5.11M Sell
9,785
-685
-7% -$370K 0.39% 69
2023
Q1
$6.03M Sell
10,470
-825
-7% -$465K 0.48% 63
2022
Q4
$6.22M Sell
11,295
-806
-7% -$427K 0.5% 64
2022
Q3
$6.14M Sell
12,101
-271
-2% -$152K 0.53% 56
2022
Q2
$6.72M Sell
12,372
-2,360
-16% -$1.3M 0.54% 56
2022
Q1
$8.7M Sell
14,732
-6,033
-29% -$3.47M 0.78% 39
2021
Q4
$13.9M Sell
20,765
-1,454
-7% -$908K 1.18% 20
2021
Q3
$12.7M Sell
22,219
-1,181
-5% -$648K 1.19% 22
2021
Q2
$11.8M Sell
23,400
-1,447
-6% -$683K 1.1% 24
2021
Q1
$11.3M Sell
24,847
-1,200
-5% -$573K 1.1% 25
2020
Q4
$12.1M Sell
26,047
-243
-0.9% -$114K 1.22% 20
2020
Q3
$11.6M Sell
26,290
-1,788
-6% -$739K 1.28% 19
2020
Q2
$10.2M Buy
28,078
+1,758
+7% +$589K 1.18% 23
2020
Q1
$7.46M Buy
26,320
+2,868
+12% +$904K 1.01% 31
2019
Q4
$7.62M Buy
23,452
+4,465
+24% +$1.35M 0.83% 35
2019
Q3
$5.53M Sell
18,987
-10
-0.1% -$2.86K 0.64% 41
2019
Q2
$5.58M Buy
18,997
+237
+1% +$65.3K 0.65% 41
2019
Q1
$5.13M Buy
18,760
+1,442
+8% +$359K 0.62% 42
2018
Q4
$3.88M Sell
17,318
-220
-1% -$51.6K 0.52% 48
2018
Q3
$4.28M Sell
17,538
-155
-0.9% -$35.7K 0.49% 49
2018
Q2
$3.67M Buy
17,693
+65
+0.4% +$13.8K 0.44% 56
2018
Q1
$3.64M Sell
17,628
-365
-2% -$76.6K 0.45% 54
2017
Q4
$3.42M Sell
17,993
-239
-1% -$45.8K 0.4% 58
2017
Q3
$3.45M Sell
18,232
-3,167
-15% -$574K 0.42% 53
2017
Q2
$3.73M Sell
21,399
-1,508
-7% -$253K 0.45% 52
2017
Q1
$3.52M Sell
22,907
-833
-4% -$127K 0.41% 54
2016
Q4
$3.35M Buy
23,740
+699
+3% +$103K 0.37% 59
2016
Q3
$3.67M Sell
23,041
-46
-0.2% -$7.09K 0.41% 53
2016
Q2
$3.41M Sell
23,087
-78
-0.3% -$11.5K 0.4% 58
2016
Q1
$3.28M Sell
23,165
-328
-1% -$44K 0.4% 56
2015
Q4
$3.33M Buy
23,493
+2,357
+11% +$314K 0.42% 56
2015
Q3
$2.58M Sell
21,136
-292
-1% -$38K 0.34% 72
2015
Q2
$2.78M Sell
21,428
-570
-3% -$74.3K 0.34% 72
2015
Q1
$2.96M Buy
21,998
+1,121
+5% +$145K 0.36% 71
2014
Q4
$2.62M Sell
20,877
-163
-0.8% -$19.8K 0.33% 76
2014
Q3
$2.56M Sell
21,040
-1,701
-7% -$207K 0.33% 72
2014
Q2
$2.68M Sell
22,741
-319
-1% -$37.5K 0.34% 72
2014
Q1
$2.77M Sell
23,060
-659
-3% -$78.3K 0.36% 69
2013
Q4
$2.64M Sell
23,719
-1,484
-6% -$148K 0.34% 72
2013
Q3
$2.32M Sell
25,203
-5,842
-19% -$528K 0.33% 73
2013
Q2
$2.63M Buy
+31,045
New +$2.58M 0.38% 64

Other funds holding TMO

Bar Harbor Wealth Management's TMO Position: Q2 2026 in Review

Bar Harbor Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 2.7% in Q2 2026, selling an estimated $77.8K and leaving 5,764 shares worth $2.89M. The position accounts for 0.16% of the portfolio, ranked #116.

Bar Harbor Wealth Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.9M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bar Harbor Wealth Management held 5,764 shares of Thermo Fisher Scientific worth $2.89M as of Q2 2026.
  • Bar Harbor Wealth Management sold 162 Thermo Fisher Scientific shares in Q2 2026, an estimated $77.8K.
  • Thermo Fisher Scientific made up 0.16% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #116 holding.
  • Bar Harbor Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Bar Harbor Wealth Management's Thermo Fisher Scientific position peaked at $13.9M in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.